FDA UDI
In Commercial Distribution
🇺🇸 United States
SourceLink™ 5.0mm Extension SourceLink™
DI: 10801741078153
·
Model: 7030310
·
Bard Brachytherapy, Inc.
Product Codes
1
GMDN Terms
1
Identifiers
2
Pkg Device Count
10
Basic Information
- Brand Name
- SourceLink™ 5.0mm Extension SourceLink™
- Primary DI
- 10801741078153
- Version / Model
- 7030310
- Catalog Number
- 7030310
- Company Name
- Bard Brachytherapy, Inc.
- Labeler DUNS
- 185524860
- Distribution Status
- In Commercial Distribution
- Device Count in Pkg
- 10
- Record Status
- Published
- Publish Date
- 2015-10-05
- Public Version
- 3
- Public Version Date
- 2022-10-31
- Public Version Status
- Update
- Public Device Record Key
- 1d7fb6a7-1296-44a5-ba03-7ebfabe7d1e3
Device Description
SourceLink™ 5.0mm Extension SourceLink™ - Model 7030310 Synthetic Absorbable Seeding Spacer Links, 10 ea
Device Characteristics
- Single Use
- Yes
- Prescription Use (Rx)
- Yes
- Over the Counter (OTC)
- No
- Kit
- No
- Combination Product
- No
- HCT/P
- No
- Contains NRL
- No
- Not Made with NRL
- No
- MRI Safety
- Labeling does not contain MRI Safety Information
- Direct Marking Exempt
- No
- PM Exempt
- No
- Has Serial Number
- No
- Has Lot/Batch Number
- Yes
- Has Manufacturing Date
- No
- Has Expiration Date
- Yes
- Has Donation ID
- No
Sterilization
- Is Sterile
- Yes
- Sterilization Prior Use
- No
Product Codes
| Code | Name | Medical Specialty | Regulation # | Device Class |
|---|---|---|---|---|
| KXK | Source, brachytherapy, radionuclide | Radiology | 892.5730 | 2 |
GMDN Terms
| Code | Name | Definition | Implantable | Status |
|---|---|---|---|---|
| 46844 | Brachytherapy source spacer | A sterile, bioabsorbable device designed to separate radioactive sources of the seed type that are permanently implanted in close proximity to a selected localized tumour, to increase the distribution of radioactivity to the tumour. It typically has a cylindrical form (of around 0.5 cm in length and less than 1 mm in diameter) and is made of bioabsorbable polymer materials. It may be used for the primary treatment of tumours (e.g., prostate cancer), or to treat unresectable tumours, recurring tumours, or residual disease. It is typically placed in the body by means of a remote-afterloading applicator using ultrasonic or fluoroscopic guidance. | Yes | Active |
Identifiers
| Type | ID | Issuing Agency | Package Type | Qty per Pkg | Pkg Status | Pkg Discontinue Date |
|---|---|---|---|---|---|---|
| Primary | 10801741078153 | GS1 | ||||
| Unit of Use | 00801741078156 | GS1 |
Customer Contacts
- Phone
- +1(800)977-6733
- [email protected]
Premarket Submissions
| Submission Number | Supplement Number |
|---|---|
| K023210 | 000 |
Storage Conditions
- Type
- Storage Environment Temperature
- Temperature Range
- High: 40 Degrees Celsius